Ergomar Tablet
NDC Package 81279-104-20

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Ergomar (ergotamine tartrate) tablets is a medication used to treat or prevent a certain type of headache (vascular headaches such as migraine headaches and cluster headaches). This formulation utilizes a tablet delivery system. Marketed by Pangea Pharmaceuticals Llc, this product is identified by NDC 81279-104 and is authorized under FDA application ANDA087693.

Identification & Billing

NDC Package Code
81279-104-20
Package Description
2 BLISTER PACK in 1 CARTON / 10 TABLET in 1 BLISTER PACK
Product Code
81279-104
11-Digit Billing Format
81279010420
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
2 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Ergomar Sublingual
Non-Proprietary Name
Ergotamine Tartrate
Substance Name
Ergotamine Tartrate
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
ERGOTAMINE TARTRATE 2 mg/1
Pharmacologic Class
Usage Information
This medication is used to treat or prevent a certain type of headache (vascular headaches such as migraine headaches and cluster headaches). Ergotamine helps narrow widened blood vessels in the head, which reduces the throbbing effects of vascular headaches.

Regulatory & Marketing

Labeler Name
Pangea Pharmaceuticals Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA087693
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-03-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (81279-104). Click a package code to view its specific billing and regulatory data.

81279-104-03
1 BLISTER PACK in 1 CARTON / 3 TABLET in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 81279-104-20 identifies a specific commercial package of 2 blister pack in 1 carton / 10 tablet in 1 blister pack of Ergomar Sublingual, a human prescription drug labeled by Pangea Pharmaceuticals Llc. This tablet is formulated for oral use and contains ergotamine tartrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pangea Pharmaceuticals Llc on February 03, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat or prevent a certain type of headache (vascular headaches such as migraine headaches and cluster headaches). Ergotamine helps narrow widened blood vessels in the head, which reduces the throbbing effects of vascular headaches.

How is this Pangea Pharmaceuticals Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 81279010420. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 2 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
81279-104-20
11-Digit CMS (5-4-2)
81279-0104-20

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.